JPH0655876B2 - Acrylamide-acrylic acid IPN - Google Patents
Acrylamide-acrylic acid IPNInfo
- Publication number
- JPH0655876B2 JPH0655876B2 JP21489089A JP21489089A JPH0655876B2 JP H0655876 B2 JPH0655876 B2 JP H0655876B2 JP 21489089 A JP21489089 A JP 21489089A JP 21489089 A JP21489089 A JP 21489089A JP H0655876 B2 JPH0655876 B2 JP H0655876B2
- Authority
- JP
- Japan
- Prior art keywords
- gel
- temperature
- ipn
- aam
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- RNIHAPSVIGPAFF-UHFFFAOYSA-N Acrylamide-acrylic acid resin Chemical compound NC(=O)C=C.OC(=O)C=C RNIHAPSVIGPAFF-UHFFFAOYSA-N 0.000 title description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 33
- 229920000642 polymer Polymers 0.000 claims description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 18
- 229920001577 copolymer Polymers 0.000 claims description 18
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 17
- 230000007704 transition Effects 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 239000003431 cross linking reagent Substances 0.000 claims description 14
- -1 alkyl methacrylate Chemical compound 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 7
- 238000004132 cross linking Methods 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000003505 polymerization initiator Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 230000035515 penetration Effects 0.000 claims description 2
- 239000000499 gel Substances 0.000 description 57
- 230000008961 swelling Effects 0.000 description 37
- 239000003814 drug Substances 0.000 description 20
- 229940079593 drug Drugs 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 16
- 230000008859 change Effects 0.000 description 16
- 239000000178 monomer Substances 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000002221 antipyretic Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000003999 initiator Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 229920005604 random copolymer Polymers 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000002522 swelling effect Effects 0.000 description 4
- 150000003926 acrylamides Chemical class 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229940125716 antipyretic agent Drugs 0.000 description 3
- 230000009918 complex formation Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2,2'-azo-bis-isobutyronitrile Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PJKNFAICTFGCDT-UHFFFAOYSA-N 2-(2-aminopropan-2-yldiazenyl)propan-2-amine;hydron;dichloride Chemical compound Cl.Cl.CC(C)(N)N=NC(C)(C)N PJKNFAICTFGCDT-UHFFFAOYSA-N 0.000 description 1
- MDZCXYVALWXHCJ-UHFFFAOYSA-N 2-tert-butylperoxy-2-methylpropane octanoic acid Chemical compound C(CCCCCCC)(=O)O.C(C)(C)(C)OOC(C)(C)C MDZCXYVALWXHCJ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 150000008049 diazo compounds Chemical class 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CHDKQNHKDMEASZ-UHFFFAOYSA-N n-prop-2-enoylprop-2-enamide Chemical class C=CC(=O)NC(=O)C=C CHDKQNHKDMEASZ-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920003224 poly(trimethylene oxide) Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000012966 redox initiator Substances 0.000 description 1
- 230000006903 response to temperature Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polymerisation Methods In General (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、温度変化により薬物送達を可能とする新規な
交互浸入網目構造を有する高分子複合体に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a polymer complex having a novel alternating intrusion network structure that enables drug delivery by changing temperature.
次世代の製剤は、長期に有効な血液中の薬物濃度を維持
することのできる薬剤、あるいは標的組織のみに薬が作
用する薬剤、すなはち、必要な量を、必要なときに、必
要な場所に薬を作用させることができる製剤であり、そ
の実現に大きな期待が寄せられている。これらのいずれ
かの概念を含むシステム化製剤を薬物送達システム(dr
ug delivery system,DDS)と呼び、一般にこのDD
Sでは前2者を放出制御型製剤、後者を標的指向型製剤
と呼んで、コントロール・リリース(controlled relea
se)の立場とターゲッティング(targeting)の立場か
ら研究がおこなわれているが、これらのすべての概念を
実現するシステム化製剤こそが理想的なDDSであり、
代謝系人工臓器、未来型の治療臓器を実現するものであ
る。Next-generation pharmaceuticals are drugs that can maintain effective drug concentrations in blood for a long period of time, or drugs that act only on target tissues, that is, the required amount, when and when needed. It is a formulation that allows drugs to act on places, and there are great expectations for its realization. A drug delivery system (dr
ug delivery system (DDS), commonly referred to as DD
In S, the former two are called controlled release preparations and the latter are targeting preparations.
Research is being conducted from the standpoint of se) and targeting, but a systemized drug that realizes all of these concepts is an ideal DDS.
It is intended to realize metabolic artificial organs and future-type therapeutic organs.
刺激応答型DDSには化学刺激応答型DDS、物理刺激
応答型DDSに分けられるが、物理刺激応答型DDSの
うち、温度に応答する薬物放出システムについても従来
より研究されている。ポリアクリルアミドゲルをアルカ
リで部分加水分解したものが水アセトン系でゲルの相転
移現象を示すことが報告されて〔田中(T.Tanaka)フィ
ジカル レビュー レターズ(Phys.Rev.Letters)40(1
2),820(1978)〕以来、アルキル置換アミドが水中で温度
変化に対してきわめて大きな膨潤変化を示すことが報告
されてきている。The stimulus responsive DDS is divided into a chemical stimulus responsive DDS and a physical stimulus responsive DDS. Among the physical stimulus responsive DDS, a drug release system that responds to temperature has been conventionally studied. It has been reported that polyacrylamide gel partially hydrolyzed with alkali shows a phase transition phenomenon of gel in water acetone system [T. Tanaka Physical Review Letters (Phys. Rev. Letters) 40 (1
2), 820 (1978)], it has been reported that alkyl-substituted amides show extremely large swelling change in water with temperature change.
本発明者らは先にアルキル置換アミドゲルが機械的強度
が低いため、2つの方法でゲルの感温性を保ちながら機
械的な強度を向上させ、膜やモノリシックデバイスを作
製した。1つはアルキル置換アクリルアミドとガラス転
移温度の低い疎水性コモノマー(たとえばブチルメタク
リレート:BMA)とのランダム共重合体であり、もう
1つはインターペネトレイトネットワーク(Inter Pene
trate Networks:IPN)を合成したものである〔表面
科学 第10巻 第2号 90〜95頁(1989)〕。Since the alkyl-substituted amide gel has low mechanical strength, the present inventors have improved the mechanical strength while maintaining the temperature sensitivity of the gel by two methods to produce a film or a monolithic device. One is a random copolymer of an alkyl-substituted acrylamide and a hydrophobic comonomer with a low glass transition temperature (eg, butyl methacrylate: BMA), and the other is an inter-penetrate network.
trate Networks: IPN) [Surface Science Vol. 10, No. 2, pp. 90-95 (1989)].
このIPNはアルキル置換アクリルアミドをラジカル重
合すると同時に、両末端水酸基のオリゴマー(ポリエチ
レンオキシド:PEO,ポリテトラメチレンオキシド:
PTMO)を3官能イソシアナートで付加重合させ、異
種のポリマー鎖を絡ませた構造をつくらせることにより
得たものである。これら従来のアルキルアミドのポリマ
ーゲル等は、低温で薬剤を放出し、高温では薬剤を放出
しないものであった。This IPN radically polymerizes alkyl-substituted acrylamide, and at the same time, oligomers of both end hydroxyl groups (polyethylene oxide: PEO, polytetramethylene oxide:
PTMO) was added to the polymer by trifunctional isocyanate to form a structure in which different polymer chains were entangled. These conventional alkylamide polymer gels and the like release drugs at low temperatures and do not release drugs at high temperatures.
従来知られている感温性ポリマーゲルは低温で膨潤性が
大きくなり、薬物放出を起こし、高温側で膨潤が急激に
小さくなって放出を停止させるタイプであり、このポリ
マーゲルを直接利用して新しい解熱剤システムをつくる
ことはできない。The conventionally known temperature-sensitive polymer gel has a large swelling property at low temperature, causes drug release, and is a type that stops swelling by rapidly reducing swelling on the high temperature side. No new antipyretic system can be created.
病気によって発熱したとき解熱剤によって熱を下げるこ
とはきわめて有効な治療であることは周知の事実であ
る。もし熱があるときにのみ作用する解熱剤の投与シス
テムがあれば、副作用の面からも子供や老人にも安全に
解熱剤を用いることができよう。温度で放出を変化させ
るポリマーゲルを用いることによって、熱のあるときに
だけ有効量の解熱剤を放出させ、薬によって熱が平熱に
戻るとただちに薬の放出が停止するような新しいタイプ
の薬剤の提出が望まれるところである。It is a well-known fact that when an illness causes fever, lowering the fever with an antipyretic is a very effective treatment. If there is an antipyretic drug administration system that works only when there is a fever, the antipyretic drug can be safely used for children and the elderly because of side effects. By using a polymer gel that changes its release with temperature, a new type of drug is submitted that releases an effective amount of antipyretic drug only in the presence of heat and stops releasing the drug as soon as the drug returns to normal temperature. Is desired.
本発明者らは、発熱したときにだけ有効量の解熱剤を放
出させ、薬により平熱に戻るとただちに薬の放出が停止
できる感温性ポリマーについて種々研究の結果、アクリ
ルアミド(AAm)とアクリル酸(AAc)の特定の共重合
体が低温収縮−高温膨潤型ゲルであり、前記の目的を達
成し得るものであることを見出し、本発明に達成したも
のである。The present inventors have conducted various studies on a temperature-sensitive polymer that releases an effective amount of an antipyretic agent only when a fever is generated, and can immediately stop the release of the drug when the drug returns to normal heat. As a result, acrylamide (AAm) and acrylic acid ( The inventors have found that the specific copolymer of AAc) is a low temperature shrinkage-high temperature swelling type gel and can achieve the above-mentioned object, and have achieved the present invention.
即ち、本発明は、転移温度以下で水素結合して安定化
し、該温度を超えると該水素結合が解離する一般式Aの
三次基共重合体と一般式Bの三次元共重合体との交互浸
入網目構造を有する架橋点間分子量が500〜10万の
高分子複合体(IPN): 〔式中、Xは架橋剤、IおよびIIは次式で示され、R1
はH又は−CH3、R2は−CnH2n+1(n=1〜2
0)、 pはポリマーゲル1gに対して約1017〜1021である。That is, the present invention provides an alternating structure of a tertiary group copolymer of the general formula A and a three-dimensional copolymer of the general formula B in which the hydrogen bond is stabilized at a transition temperature or lower, and the hydrogen bond dissociates when the temperature is exceeded. Polymer composite (IPN) having an infiltration network structure and a molecular weight between cross-linking points of 500 to 100,000: [Wherein X is a cross-linking agent, I and II are represented by the following formula, and R 1
Is H or —CH 3 , and R 2 is —C n H 2n + 1 (n = 1 to 2)
0), p is about 10 17 to 10 21 with respect to 1 g of the polymer gel.
およびその製造法に関する。 And its manufacturing method.
本発明のIPNはアクリルアミド(AAm)−アクリル
酸(AAc)IPNである。IPNとはインターペネト
レイトネットワーク(Inter Penetrate Networks:IP
N)であり、架橋高分子が交互浸入網目構造に、共有結
合でなく、物理的にからみ合っている複合体である。The IPN of the present invention is acrylamide (AAm) -acrylic acid (AAc) IPN. What is IPN? Inter Penetrate Networks (IP)
N), which is a complex in which the cross-linked polymer is physically entangled in the alternating penetration network structure, not by covalent bond.
そして、本発明のIPNについては、AAmとAAcは
転移温度以下で式I及びIIで示されるように、水素結合
によりコンプレックスを形成した構造によって安定化し
ている。そして、このコンプレックスは温度上昇により
解離できるシステムを構成する。特に水中に低温側にお
いては、このコンプレックスは安定であるが、温度上昇
によって急激にこのコンプレックスが破壊される特徴を
有する。すなわち水中で低温側では低膨潤性を示すが、
転移温度(T.P)以上になると水素結合が切れて急激
に膨潤を増大させる。Then, in the IPN of the present invention, AAm and AAc are stabilized by a structure in which a complex is formed by a hydrogen bond as shown in Formulas I and II below the transition temperature. Then, this complex constitutes a system that can be dissociated by increasing the temperature. In particular, this complex is stable on the low temperature side in water, but it has the characteristic that this complex is rapidly destroyed by the temperature rise. That is, it shows a low swelling property in the low temperature side in water,
When the temperature exceeds the transition temperature (TP), hydrogen bonds are broken and the swelling is rapidly increased.
転移温度(T.P)はIおよびII中のアルキルメタクリ
レート組成によって任意に制御される。すなわち、アル
キルメタクリレート組成の増大によってT.Pを10℃〜
50℃の間で制御し得る。The transition temperature (TP) is optionally controlled by the alkylmethacrylate composition in I and II. That is, by increasing the alkyl methacrylate composition, T. P to 10 ℃
It can be controlled between 50 ° C.
IおよびIIの分子量を架橋点間分子量で示すと約500〜
約10万である。この架橋点間分子量は合成時のモノマー
量と架橋剤濃度により次式に従って求めることができ
る。When the molecular weights of I and II are indicated by the molecular weight between cross-linking points, it is about 500
It is about 100,000. This inter-crosslinking point molecular weight can be determined according to the following formula based on the amount of monomer and the concentration of the crosslinking agent at the time of synthesis.
を形成するモノマー分子数 I又はIIのモル分子量=(AAm又はAAc分子量)×
a×I又はIIを形成するモノマー分子数+(BMA分子
量)×b×I又はIIを形成するモノマー分子数 (a,bは第1ゲル又は第2ゲル中のAAm又はAA
c,BMAの含率) 本発明の場合、架橋濃度は0.005モル%〜10モル%であ
るから、IおよびIIの架橋間分子量は約500〜約10万の
範囲で変化する。 Number of monomer molecules forming I Molar molecular weight of I or II = (AAm or AAc molecular weight) x
a × I or II forming monomer molecules + (BMA molecular weight) × b × I forming monomer molecules forming I or II (a and b are AAm or AA in the first gel or the second gel)
c, Content of BMA) In the present invention, since the crosslinking concentration is 0.005 mol% to 10 mol%, the inter-crosslinking molecular weights of I and II vary in the range of about 500 to about 100,000.
又、 はIおよびIIを形成するモノマー組成を示すものであ
り、元素分析値より計算して求めることができる。or, Represents the composition of monomers forming I and II, and can be calculated from elemental analysis values.
本発明のアクリルアミド−アクリル酸IPNは、例えば
次のようにして製造される。The acrylamide-acrylic acid IPN of the present invention is produced, for example, as follows.
SIPN(Sequential Interpenetrating Polymer Netw
ork)法 1.アクリルアミド(AAm)、アルキルメタクリレー
ト又はアルキルアクリレート、架橋剤、重合開始剤を溶
媒中に溶解し、窒素気流中で攪拌し、ガラス板上で反応
させ、ついで、生成した膜をジメチルスルホキシド(D
MSO)及び精製水で洗浄してポリアクリルアミドゲル
を得る。SIPN (Sequential Interpenetrating Polymer Netw)
ork) method 1. Acrylamide (AAm), alkyl methacrylate or alkyl acrylate, a cross-linking agent, and a polymerization initiator are dissolved in a solvent, stirred in a nitrogen stream, reacted on a glass plate, and then the resulting film is treated with dimethyl sulfoxide (D).
MSO) and purified water to obtain polyacrylamide gel.
架橋剤としては以下のもの、例えば (1)ジアクリルおよびメタクリル誘導体 R1;−H又は−CH3 R2;−H又は−CH3 n=1〜100 R1;−CH3、R2;H、n=1のとき、エチレングリ
コールジメタクリレート (2)ジアクリルアミド誘導体 メチレンビスアクリルアミド (3)ジビニル誘導体 ジビニルベンゼン 4)ジアリル誘導体 ジアリルフタレート等が挙げられる。Examples of the cross-linking agent include the following (1) diacryl and methacryl derivatives R 1 ; -H or -CH 3 R 2 ; -H or -CH 3 n = 1 to 100 R 1 ; -CH 3 , R 2 ; H, when n = 1, ethylene glycol dimethacrylate (2) diacrylamide Derivative Methylenebisacrylamide (3) Divinyl derivative Divinylbenzene 4) diallyl derivative Examples thereof include diallyl phthalate.
開始剤は過酸化物、〔過酸化オクタン酸t−ブチル(B
PO)等〕、ジアゾ化合物〔NN′−アゾビスイソブチ
ロニトリル(AIBN)等〕、溶媒はジメチルスルホキ
シド(DMSO)及びDMSOと水、アルコール、ジオ
キサン、ジメチルホルムアミド、(DMF)等の混合溶
媒等が使用される。The initiator was peroxide, [t-butyl peroxide octanoate (B
PO) etc.], diazo compound [NN′-azobisisobutyronitrile (AIBN) etc.], the solvent is dimethyl sulfoxide (DMSO) and a mixed solvent of DMSO and water, alcohol, dioxane, dimethylformamide, (DMF), etc. Is used.
アルキルメタクリレート又はアルキルアクリレートは、
AAmのみでは強度が低いので導入される。この含有量
はAAmに対して0〜0.7モル分率で用いられる。又、
架橋剤の量は全モノマーに対して0.005モル%〜10モル
%である。Alkyl methacrylate or alkyl acrylate is
Since only AAm has low strength, it is introduced. This content is used at 0 to 0.7 mole fraction with respect to AAm. or,
The amount of cross-linking agent is 0.005 mol% to 10 mol% based on the total monomers.
反応温度は20〜90℃、好ましくは60〜80℃、反応時間は
1〜72時間、好ましくは12〜48時間である。The reaction temperature is 20 to 90 ° C, preferably 60 to 80 ° C, and the reaction time is 1 to 72 hours, preferably 12 to 48 hours.
2.アクリルアミド−アクリル酸IPNの合成 第一ゲルにアクリル酸(AAc)、アルキルメタクリレ
ート又はアルキルアクリレート、架橋剤を含浸重合させ
て、AAm−AAcIPNを合成する。これはAAc水
溶液中に第一ゲルを浸し、膨潤させる方法により行なう
ことができる。AAc水溶液の濃度は、第一ゲル中のA
Am濃度と等しくなるように、AAcを導入する前に第
一ゲルの含水率を測定し、第一ゲル中の含水量とAAm
量からAAm濃度を計算し、この濃度とほぼ等しいAA
c水溶液を調節する。このAAm濃度とほぼ等しいAA
c水溶液に架橋剤、開始剤を加え、第二モノマー溶液を
調製し、この第二モノマー溶液に上記で製造した第一ゲ
ルを浸し、その後ガラス板ではさみ加熱し、ついで精製
水で洗浄し、IPNを合成する。2. Synthesis of acrylamide-acrylic acid IPN AAm-AAcIPN is synthesized by impregnating and polymerizing acrylic acid (AAc), alkyl methacrylate or alkyl acrylate, and a crosslinking agent in the first gel. This can be performed by immersing the first gel in an AAc aqueous solution and allowing it to swell. The concentration of the AAc aqueous solution is A in the first gel.
The water content of the first gel was measured before introducing AAc so as to be equal to the Am concentration, and the water content and AAm in the first gel were measured.
The AAm concentration is calculated from the amount, and the AA is almost equal to this concentration.
c Adjust the aqueous solution. AA almost equal to this AAm concentration
c A cross-linking agent and an initiator are added to the aqueous solution to prepare a second monomer solution, the first gel prepared above is dipped in the second monomer solution, and then the glass plate is heated with scissors and then washed with purified water, Synthesize IPN.
この合成における架橋剤及びその割合は前記第一ゲルの
製造の場合と同じである。又、開始剤は、過硫酸アンモ
ニウム、等のレドックス開始剤及び2,2′−アゾビス
(2−アミノプロパン)ジハイドロクロライド等の水溶
性ジアゾ開始剤等であり、その添加量は全容量(モノマ
ー+溶媒に対し0.001〜0.1モル/)である。The cross-linking agent and the proportion thereof in this synthesis are the same as in the case of producing the first gel. Further, the initiator is a redox initiator such as ammonium persulfate and a water-soluble diazo initiator such as 2,2′-azobis (2-aminopropane) dihydrochloride, and the addition amount thereof is the total volume (monomer + monomer It is 0.001 to 0.1 mol /) with respect to the solvent.
第二モノマー溶液への第一ゲルの浸漬時間は1〜48時間
であり、又浸された第一ゲルのガラス板での加熱温度は
20〜90℃、好ましくは30〜70℃、加熱時間は〜1時間以
上〜10日程度である。The immersion time of the first gel in the second monomer solution is 1 to 48 hours, and the heating temperature of the immersed first gel on the glass plate is
20 to 90 ° C., preferably 30 to 70 ° C., and the heating time is about 1 hour or more and about 10 days.
本発明のAAm−AAcIPNは、精製水中において、
温度変化に対して低温側では不透明に、高温側では透明
になることがわかった。これは低温側ではAAc−AA
m間で水素結合によるポリマーコンプレックスを形成し
ているために相分離を起こし、一方温度が上昇するとコ
ンプレックスの水素結合が切れるためにゲルの膨潤性を
増大させていることを示すものであり、この様な低温収
縮−高温膨潤型ポリマーゲルにより、例えば熱のあると
きにだけ有効量の解熱剤を放出させ、薬によって熱が平
熱に戻るとただちに薬の放出が停止するような、温度変
化に対してON−OFF制御の可能なあたらしいタイプ
の薬剤の実現が可能となる。AAm-AAcIPN of the present invention, in purified water,
It was found that it became opaque on the low temperature side and transparent on the high temperature side with respect to temperature changes. This is AAc-AA on the low temperature side.
It is shown that phase separation occurs due to the formation of a polymer complex due to hydrogen bonding between m and the swelling property of the gel is increased because the hydrogen bonding of the complex is broken when the temperature rises. Such a low temperature shrinkage-high temperature swelling polymer gel allows for a change in temperature such that an effective amount of the antipyretic agent is released only in the presence of heat, and the release of the drug is stopped as soon as the drug returns to normal temperature. It is possible to realize a new type of drug that can be turned on and off.
以下に本発明の実施例を記載するが、本発明はこれらの
実施例に限定されるものではない。Examples of the present invention will be described below, but the present invention is not limited to these examples.
1.AAm−AAc IPNの合成 (1)AAm−BMA共重合ゲル(第1ゲル)の合成 アクリルアミド(AAm)にt−ブチルメタクリレート
(BMA),架橋剤メチレンビスアクリルアミド(MB
AAm)を第1表に示す仕込み量で50mlのメスシリ
ンダーの中に入れ、充分に脱気した溶媒ジメチルスルホ
キシド(DMSO)を全部で20mlになるように加え
て溶解し、このモノマー溶液を15分間窒素でバブリン
グし、その後重合開始剤過酸化オクタン酸t−ブチル
(BPO)を加えて攪拌し、スペーサーのついたガラス
板に流し込んだ。これを80℃で24時間加熱反応し、
生成した膜をDMSO及び精製水で十分に洗浄し、AA
m−BMA共重合ゲル(第1ゲル)を合成した。1. Synthesis of AAm-AAc IPN (1) Synthesis of AAm-BMA copolymer gel (1st gel) Acrylamide (AAm) with t-butylmethacrylate (BMA) and cross-linking agent methylenebisacrylamide (MB)
AAm) was placed in a 50 ml graduated cylinder in the amount shown in Table 1, and fully degassed solvent dimethyl sulfoxide (DMSO) was added to dissolve it to a total of 20 ml and dissolved, and this monomer solution was added for 15 minutes. After bubbling with nitrogen, a polymerization initiator t-butyl peroxide octanoate (BPO) was added, and the mixture was stirred and poured into a glass plate with a spacer. This is heated and reacted at 80 ° C. for 24 hours,
Thoroughly wash the resulting membrane with DMSO and purified water to obtain AA
An m-BMA copolymer gel (first gel) was synthesized.
AAm−BMA共重合ゲルの物性はそれぞれ第2表のと
おりである。The physical properties of the AAm-BMA copolymer gel are shown in Table 2, respectively.
(2)アクリルアミド−アクリル酸IPNの合成 第4表に示す濃度でAAC水溶液を調製し、この溶液に
架橋剤として0.5mol%のメチレンビスアクリルアミド
(MBAAm)と開始剤として過硫酸アンモニウム2.0g
/dm3を加え、第二モノマー溶液を作った。これに上記の
第1ゲルを24時間浸し、その後ガラス板ではさみ50
℃で1時間加熱した。生成したIPNを1週間以上精製
水で洗浄しアクリルアミド−アクリル酸IPNを合成し
た。 (2) Synthesis of acrylamide-IPN acrylate An AAC aqueous solution was prepared at the concentration shown in Table 4, and 0.5 mol% methylenebisacrylamide (MBAAm) as a crosslinking agent and 2.0 g of ammonium persulfate as an initiator were added to the solution.
/ dm 3 was added to make a second monomer solution. Soak the above first gel in this for 24 hours, and then scissor it with a glass plate.
Heated at ° C for 1 hour. The produced IPN was washed with purified water for 1 week or more to synthesize acrylamide-acrylic acid IPN.
得られたIPNの物性を第5表に示す。なお第3表は第
1ゲルのAAm濃度であり、これを基準として第4表に
示すAAC濃度を選択し、AAm−AAc IPNを合
成した。Table 5 shows the physical properties of the obtained IPN. Table 3 shows the AAm concentration of the first gel, and the AAC concentration shown in Table 4 was selected based on this to synthesize AAm-AAc IPN.
得られたIPNのAAmとAAc間で水素結合している
ことは水素結合部分であるアミド基とカルボキシル基の
IR吸収波長の変化を見ることにより分る。IPNにす
る前と後のアクリルアミドのN−H変角振動(アミドII
吸収)の変化を見ると、第一ゲルでは1605cm-1付近に認
められるのに対して、IPNでは1590cm-1付近に認めら
れた。即ち、IPNにするとそのピークが低波数側にシ
フトする。これはAAmとAAc間で水素結合が生じた
ことによるものである。 The hydrogen bond between AAm and AAc of the obtained IPN can be seen by observing the change in the IR absorption wavelength of the amide group and the carboxyl group, which are hydrogen bonding parts. N-H bending vibration of acrylamide before and after IPN (amide II
Absorption) was observed in the vicinity of 1605 cm -1 in the first gel, whereas it was observed in the vicinity of 1590 cm -1 in IPN. That is, when the IPN is selected, the peak shifts to the low wave number side. This is because a hydrogen bond was generated between AAm and AAc.
2.ランダムAAm-BMA-AAc共重合体の合成 比較のため、第6表に示すモノマーの仕込み量で重合
し、ランダムAAm-BMA-AAc共重合体を得た。 2. Synthesis of Random AAm-BMA-AAc Copolymer For comparison, a random AAm-BMA-AAc copolymer was obtained by polymerizing at the charged amounts of the monomers shown in Table 6.
得られた共重合体の物性として、元素分析結果及び膨潤
度を第7表に示す。 Table 7 shows the results of elemental analysis and the degree of swelling as the physical properties of the obtained copolymer.
3.第一ゲル、IPN、ランダム重合体ゲルの平衡膨潤
度の温度依存性の測定 精製水中で各設定温度における平衡膨潤度をポリマー1
g当りの水含有量(ws/wp)で測定し、それぞれ第1〜第
4図に示した。 3. Measurement of the temperature dependence of the equilibrium swelling degree of the first gel, IPN, and random polymer gel.
The water content per gram (ws / wp) was measured and is shown in FIGS. 1 to 4, respectively.
なお、この平衡膨潤度は次のようにして測定した。即
ち、あらかじめ精秤したゲル試料(Wpg)を所定温度
の蒸留水中に浸漬させ、時間変化に対し重量変化しなく
なった膨潤ゲル試料の重量(Ws)を測定し膨潤度Qを
以下の式によって求めた。The equilibrium swelling degree was measured as follows. That is, a gel sample (Wpg) that has been precisely weighed in advance is immersed in distilled water at a predetermined temperature, the weight (Ws) of the swollen gel sample that does not change in weight over time is measured, and the swelling degree Q is calculated by the following formula. It was
第1図は第一ゲル(AAm/BMAゲル)の平衡膨潤度
の温度依存性を示すグラフであり、これらはいずれも温
度によりその平衡膨潤度は変わらないことを示してい
る。なお、AAcポリマーゲルにおいては温度上昇と共
に平衡膨潤度は大となることを示すが、その上昇は単調
であり、急激なものでないことを示している。 FIG. 1 is a graph showing the temperature dependence of the equilibrium swelling degree of the first gel (AAm / BMA gel), which shows that the equilibrium swelling degree does not change with temperature. In the AAc polymer gel, the equilibrium swelling degree increases with increasing temperature, but the increase is monotonous and not abrupt.
第2図はAAm/BMA-AAc/BMA IPN系ゲル
の平衡膨潤度の温度依存性を示すグラフである。本発明
のIPNゲルは温度の変化と共に平衡膨潤度が急激に増
加する転移温度を有することを表している。この転移温
度は共重合体の疎水性を増大させると高温側にシフトさ
せることができる。即ち、アルキルメタクリレート或い
はアルキルアクリレート組成比を増すと転移温度を上昇
させることができる。又アルキルメタクリレート或いは
アルキルアクリレートにおいて、アルキルの炭素数を増
大させると転移温度を上昇させることができる。そし
て、転移温度を10〜50℃の範囲で任意に設定制御するこ
とができる。このIPNは高温側で透明に膨潤し、低温
側では膜が白濁している。FIG. 2 is a graph showing the temperature dependence of the equilibrium swelling degree of AAm / BMA-AAc / BMA IPN gel. The IPN gel of the present invention has a transition temperature at which the equilibrium swelling degree increases rapidly with changes in temperature. This transition temperature can be shifted to the higher temperature side by increasing the hydrophobicity of the copolymer. That is, the transition temperature can be raised by increasing the composition ratio of alkyl methacrylate or alkyl acrylate. Further, in the alkyl methacrylate or the alkyl acrylate, the transition temperature can be raised by increasing the carbon number of the alkyl. The transition temperature can be arbitrarily set and controlled within the range of 10 to 50 ° C. This IPN swells transparently on the high temperature side, and the film becomes cloudy on the low temperature side.
第3図はランダムAAm-BMA-AAc共重合体ゲルの
平衡膨潤度の温度依存性を示すグラフである。ランダム
共重合体ゲルの場合はAAc共重合体ゲルと同じく温度
上昇による膨潤度の上昇が単調であり、鈍いことを示し
ている。FIG. 3 is a graph showing the temperature dependence of the equilibrium swelling degree of a random AAm-BMA-AAc copolymer gel. In the case of the random copolymer gel, the increase in the degree of swelling due to the temperature increase is monotonous, which is similar to the case of the AAc copolymer gel, indicating that it is slow.
第4図はIPNとAAm/BMA-10及びAAm-AA
cランダム共重合体ゲルの平衡膨潤度の温度依存性の比
較のグラフである。この図から明らかなようにAAm/
BMAゲルやAAm-AAcランダム共重合体ゲルの膨
潤度が温度に対してほとんど変化しないが、温度上昇に
対して鈍い上昇をするのに対して、本発明のIPNの膨
潤度は温度上昇に対して転移温度において鋭く上昇する
ことを示している。収縮した状態から膨潤した状態に変
化する温度は、疎水性モノマー組成によって0〜50℃の
範囲で任意の温度で制御可能である。Figure 4 shows IPN and AAm / BMA-10 and AAm-AA
It is a graph of comparison of the temperature dependence of the equilibrium swelling degree of c random copolymer gel. As is clear from this figure, AAm /
Although the swelling degree of BMA gel or AAm-AAc random copolymer gel hardly changes with temperature, the swelling degree of IPN of the present invention increases with temperature increase, while the swelling degree of IPN of the present invention increases with temperature. It shows a sharp rise in the transition temperature. The temperature at which the contracted state changes to the swollen state can be controlled at any temperature within the range of 0 to 50 ° C. depending on the hydrophobic monomer composition.
4.IPNの感温性の時間依存性 IPNの感温性の時間依存性を測定した。これは温度A
の恒温水中で平衡膨潤状態に達した含水ゲル試料を温度
Bの恒温水中に移した後、経時的に含水ゲル試料の重量
を測定し、時間に対する膨潤度変化を求め、さらに温度
Bから温度Aの恒温水中に再び戻し、膨潤度変化の時間
依存性を同様に求めたものである。4. Time Dependence of Temperature Sensitivity of IPN The time dependency of temperature sensitivity of IPN was measured. This is temperature A
After the hydrous gel sample that has reached the equilibrium swelling state in the constant temperature water is transferred to the constant temperature water at the temperature B, the weight of the hydrous gel sample is measured over time, and the swelling degree change with time is obtained. It was returned to the constant temperature water again and the time dependence of the change in swelling degree was similarly obtained.
IPN(AAm/BMA-10)の感温性を第5図に示す。10℃から
30℃に温度変化させた場合、1回目に比べ2回目以降で
は温度変化に対し速い膨潤変化を示した。これは1回目
の温度変化によってA鎖とB鎖の再配列を引き起こし、
より安定な部位で水素結合による高分子コンプレックス
を生成するためであると思われる。このことは、一度ゲ
ルを水中で温度処理(高温にする)することによって温
度に速く応答して膨潤変化するゲルができることを示し
ている。The temperature sensitivity of IPN (AAm / BMA-10) is shown in FIG. From 10 ℃
When the temperature was changed to 30 ° C., the swelling change was rapid with respect to the temperature change after the second time as compared with the first time. This causes rearrangement of A chain and B chain by the first temperature change,
This is probably because a polymer complex by hydrogen bonding is generated at a more stable site. This indicates that once the gel is subjected to a temperature treatment (increased in temperature) in water, a gel that swells and changes in response to temperature quickly is formed.
BMA含有率が10%の場合:およそAAmとAAcの
モル比が1:1の比率でそれぞれがゲル中に入ってお
り、コンプレックス形成の理想的状態と言えるものであ
り、温度に対する大きな膨潤変化、速い可逆的膨潤変化
を示す。このことはBMA含有率20%の場合も同様な
結果を得ることができる。When the BMA content is 10%: Each of them is contained in the gel at a molar ratio of AAm and AAc of about 1: 1, which can be said to be an ideal state of complex formation, and a large swelling change with temperature, It shows a fast reversible swelling change. The same result can be obtained when the BMA content is 20%.
さらにBMA含有率の10%のIPNは精製水中におい
て温度変化に対し低温側では不透明に、高温側では透明
になることがわかった。これは低温側でAAc-AAm
間で水素結合によるポリマーコンプレックスを形成して
いるために相分離を起こし、一方温度が上昇するとコン
プレックスの水素結合が切れるためにゲルの膨潤性を増
大させていることを示している。これに対し疎水性のコ
モノマー(ブチルメタクリレート等)がない場合には可
逆的膨潤変化は示さない。これは疎水性のコモノマーが
ないと高膨潤度になり、一度高膨潤度になってしまうと
ゲル中にAAmおよびAAc濃度が非常に低くなってし
まうために、再びコンプレックスができにくくなるため
である。疎水性モノマーの存在は、IPNの膨潤度を制
御することになり、これによりコンプレックス形成の可
逆性が実現されるのである。さらに、この疎水性モマー
の量を調節することによりコンプレックスの形成、転移
温度(解離温度)を制御できる。この様な低温収縮−高
温膨潤型ゲルを用いることによって、熱のあるときだけ
有効量を解熱剤で放出させ、平熱に戻ると薬の放出が停
止するような薬物放出制御が実現できる。Further, it was found that IPN having a BMA content of 10% became opaque on the low temperature side and became transparent on the high temperature side in the purified water against the temperature change. This is AAc-AAm on the low temperature side
It is shown that phase separation occurs due to the formation of a polymer complex due to hydrogen bonding between the two, and on the other hand, the swelling property of the gel is increased because the hydrogen bonding of the complex is broken when the temperature rises. On the other hand, no reversible swelling change is shown when there is no hydrophobic comonomer (butyl methacrylate etc.). This is because if there is no hydrophobic comonomer, the degree of swelling becomes high, and once the degree of swelling becomes high, the concentration of AAm and AAc in the gel becomes extremely low, and it becomes difficult to form a complex again. . The presence of the hydrophobic monomer controls the degree of swelling of the IPN, thereby realizing the reversibility of complex formation. Furthermore, the complex formation and transition temperature (dissociation temperature) can be controlled by adjusting the amount of this hydrophobic momer. By using such a low temperature shrinkage / high temperature swelling type gel, it is possible to realize drug release control in which an effective amount is released with an antipyretic agent only when there is heat and the release of the drug is stopped when the temperature returns to normal heat.
第1図はAAm/BMA系ゲルの平衡膨潤度の温度依存
性グラフ、第2図はIPN(AAm/BMA)系ゲルの
平衡膨潤度の温度依存性グラフ、第3図はランダムAA
m−AAc共重合体系ゲルの平衡膨潤度の温度依存性グ
ラフ、第4図はIPN(AAm/BMA−10)とAA
m/BMA−10及びランダムAAm−AAc−10共
重合体の平衡膨潤度の温度依存性グラフ、第5図は10
℃と30℃での水中におけるIPN(AAm/BMA−
10)の膨潤度の可逆変化を示すグラフである。FIG. 1 is a temperature dependence graph of the equilibrium swelling degree of the AAm / BMA gel, FIG. 2 is a temperature dependence graph of the equilibrium swelling degree of the IPN (AAm / BMA) gel, and FIG. 3 is a random AA.
Graph of temperature dependence of equilibrium swelling degree of m-AAc copolymer gel, FIG. 4 shows IPN (AAm / BMA-10) and AA
m / BMA-10 and random AAm-AAc-10 copolymer temperature dependence graph of equilibrium swelling degree, FIG.
IPN (AAm / BMA- in water at ℃ and 30 ℃
It is a graph which shows the reversible change of the swelling degree of 10).
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C08F 220/18 MMD 7242−4J 220/56 MNC 7242−4J C08L 33/26 LHV 7921−4J ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location C08F 220/18 MMD 7242-4J 220/56 MNC 7242-4J C08L 33/26 LHV 7921-4J
Claims (4)
温度を超えると該水素結合が解離する一般式Aの三次元
共重合体と一般式Bの三次元共重合体との交互浸入網目
構造を有する架橋点間分子量が500〜10万の高分子
複合体(IPN)。 〔式中、Xは架橋剤、IおよびIIは次式で示され、R1
はH又は−CH3、R2は−CnH2n+1(n=1〜2
0)、 pはポリマーゲル1gに対して約1017〜1021である。 1. Alternating infiltration of a three-dimensional copolymer of the general formula A and a three-dimensional copolymer of the general formula B, which is stabilized by hydrogen bonding below the transition temperature and is dissociated above the temperature. A polymer composite (IPN) having a network structure and a molecular weight between crosslinking points of 500 to 100,000. [Wherein X is a cross-linking agent, I and II are represented by the following formula, and R 1
Is H or —CH 3 , and R 2 is —C n H 2n + 1 (n = 1 to 2)
0), p is about 10 17 to 10 21 with respect to 1 g of the polymer gel.
記載の高分子複合体。2. The transition temperature is between 10 ° C. and 50 ° C.
The polymer composite described.
クリレート又はアルキルアクリレート、架橋剤及び重合
開始剤を溶媒中に溶解し、板上で反応させ、第一ゲルで
あるポリアクリルアミドゲルを得、該第一ゲルをアクリ
ル酸(AAc)、アルキルメタクリレート又はアルキル
アクルレート、架橋剤及び重合開始剤を含む溶液に含浸
し、重合することを特徴とする転移温度以下で水素結合
して安定化し、該温度を超えると該水素結合が解離する
一般式Aの三次元共重合体と一般式Bの三次元共重合体
との交互浸入網目構造を有する架橋点間分子量が500
〜10万の高分子複合体(IPN)の製造方法。 〔式中、Xは架橋剤、IおよびIIは次式で示され、R1
はH又は−CH3、R2は−CnH2n+1(n=1〜20)、 pはポリマーゲル1gに対して約1017〜1021である。 3. Acrylamide (AAm), alkyl methacrylate or alkyl acrylate, a cross-linking agent and a polymerization initiator are dissolved in a solvent and reacted on a plate to obtain a polyacrylamide gel which is a first gel. Is impregnated with a solution containing acrylic acid (AAc), an alkyl methacrylate or an alkyl acrylate, a cross-linking agent and a polymerization initiator, and polymerized to hydrogen bond and stabilize at a transition temperature or lower. The intermolecular molecular weight between cross-linking points having an alternating penetration network structure of the three-dimensional copolymer of the general formula A and the three-dimensional copolymer of the general formula B in which the hydrogen bond is dissociated is 500.
A method for producing a polymer composite (IPN) of 100,000. [Wherein X is a cross-linking agent, I and II are represented by the following formula, and R 1
Is H or —CH 3 , R 2 is —C n H 2n + 1 (n = 1 to 20), p is about 10 17 to 10 21 with respect to 1 g of the polymer gel.
リレート組成により10〜50℃の間で制御する、請求項3
記載の高分子複合体の製造方法。4. The transition temperature is controlled between 10 and 50 ° C. by the composition of alkyl methacrylate in I and II.
A method for producing the polymer composite described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21489089A JPH0655876B2 (en) | 1989-08-23 | 1989-08-23 | Acrylamide-acrylic acid IPN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21489089A JPH0655876B2 (en) | 1989-08-23 | 1989-08-23 | Acrylamide-acrylic acid IPN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0379608A JPH0379608A (en) | 1991-04-04 |
| JPH0655876B2 true JPH0655876B2 (en) | 1994-07-27 |
Family
ID=16663262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21489089A Expired - Fee Related JPH0655876B2 (en) | 1989-08-23 | 1989-08-23 | Acrylamide-acrylic acid IPN |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0655876B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106235A1 (en) * | 2023-11-13 | 2025-05-22 | Buckman Laboratories International, Inc. | Interpenetrating polymer network for paper and paperboard coating compositions |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2101773A1 (en) * | 1991-01-31 | 1992-08-01 | Toyoichi Tanaka | Interpenetrating-polymer network phase-transition gels |
| KR0121127B1 (en) * | 1994-05-09 | 1997-11-13 | 강박광 | Transdermal drug delivery system having ionic polymer network |
| WO2000002937A1 (en) | 1998-07-08 | 2000-01-20 | Sunsoft Corporation | Interpenetrating polymer network hydrophilic hydrogels for contact lens |
| DE60040411D1 (en) * | 1999-11-19 | 2008-11-13 | Nof Corp | RELIABLE RELEASE AND METHOD FOR THE PRODUCTION THEREOF |
| AU2002309026A1 (en) | 2002-05-01 | 2003-11-17 | Hokkaido Technology Licensing Office Co., Ltd. | Gel having multiple network structure and method for preparation thereof |
| WO2006013612A1 (en) | 2004-06-18 | 2006-02-09 | Hokkaido Technology Licensing Office Co., Ltd. | Artificial semilunar cartilage |
| JP2006213868A (en) * | 2005-02-04 | 2006-08-17 | Hokkaido Univ | Gel and method for producing the same |
| JP4549410B2 (en) * | 2007-08-01 | 2010-09-22 | 株式会社 GEL−Design | Polymer gel composite and method for producing the same |
| WO2009099210A1 (en) * | 2008-02-08 | 2009-08-13 | Mitsubishi Rayon Co., Ltd. | Hydrogel and process for producing the same |
| JP5556406B2 (en) * | 2010-06-15 | 2014-07-23 | 三菱レイヨン株式会社 | Gel and method for producing the same |
| JP7248967B2 (en) * | 2018-04-23 | 2023-03-30 | 国立大学法人北海道大学 | Hydrogel and method for producing hydrogel |
| CN114085317B (en) * | 2021-12-22 | 2023-01-03 | 中国医学科学院生物医学工程研究所 | Reactive UCST copolymer and preparation method thereof |
| CN114561237B (en) * | 2022-04-19 | 2022-10-28 | 中国科学院兰州化学物理研究所 | Preparation method of shear-responsive water-based gel lubricant |
-
1989
- 1989-08-23 JP JP21489089A patent/JPH0655876B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106235A1 (en) * | 2023-11-13 | 2025-05-22 | Buckman Laboratories International, Inc. | Interpenetrating polymer network for paper and paperboard coating compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0379608A (en) | 1991-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2027930C (en) | Polymer complexes of a sugar response type | |
| KARADAĞ et al. | Swelling of superabsorbent acrylamide/sodium acrylate hydrogels prepared using multifunctional crosslinkers | |
| Park et al. | Novel pH‐sensitive polymers containing sulfonamide groups | |
| Vakkalanka et al. | Temperature-and pH-sensitive terpolymers for modulated delivery of streptokinase | |
| Baker et al. | Swelling equilibria for acrylamide-based polyampholyte hydrogels | |
| JPH0655876B2 (en) | Acrylamide-acrylic acid IPN | |
| Karadağ et al. | Water uptake in chemically crosslinked poly (acrylamide-co-crotonic acid) hydrogels | |
| EP0263605B1 (en) | Wound dressing | |
| SE448545B (en) | WATER-ABSORBING COMPOSITION AND USE THEREOF, AS A CARRIER FOR MEDICINAL PRODUCTS OR TRANSFER OF CATHETRES, SUTURES AND GLASS SURFACES | |
| Katime et al. | Controlled release of aminophylline from poly (N‐isopropylacrylamide‐co‐itaconic acid) hydrogels | |
| US4889530A (en) | Wound dressing containing acrylate or methacrylate hydrogel polymer | |
| Kuo et al. | Synthesis of pH-sensitive sulfonamide-based hydrogels with controllable crosslinking density by post thermo-curing | |
| JP3121660B2 (en) | Thermoreversible hydrogel material | |
| Liu et al. | Thermo-and pH-sensitive comb-type grafted poly (N, N-diethylacrylamide-co-acrylic acid) hydrogels with rapid response behaviors | |
| Bell et al. | Swelling/syneresis phenomena in gel-forming interpolymer complexes | |
| CN104693347A (en) | Metal ion cross-linked nanogel with zwitter-ion structure and preparing method thereof | |
| Andreopoulos | Properties of poly (2-hydroxyethyl acrylate) networks | |
| KR100447838B1 (en) | Carboxylated polymer composition | |
| Atta et al. | Synthesis of charged linear and crosslinked maleic diester polymers with electron‐beam irradiation | |
| Kubota et al. | Temperature‐responsive properties of poly (acrylic acid‐co‐acrylamide)‐graft‐oligo (ethylene glycol) hydrogels | |
| Lee et al. | Poly (2-hydroxyethyl methacrylate-co-sulfobetaine) s hydrogels: 3. Synthesis and swelling behaviors of the [2-hydroxyethyl methacrylate-co-N, N′-dimethyl (acrylamido propyl) ammonium propane sulfonate] hydrogels | |
| Deen et al. | Determination of reactivity ratios and swelling characteristics of ‘stimuli’responsive copolymers of N-acryloyl-N′-ethyl piperazine and MMA | |
| Vazquez et al. | pH-Sensitive hydrogels based on non-ionic acrylic copolymers | |
| JPS6155180A (en) | Nonionic gel | |
| Sastre et al. | Cytarabine trapping in poly (2‐hydroxyethyl methacrylate‐co‐acrylamide) hydrogels: drug delivery studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |